Buprenorphine and Naloxone
NDC 31722-851, Buprenorphine and Naloxone, tablet, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-851
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219727
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/31722-851 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-851-30 | 31722085130 | 30 TABLET in 1 BOTTLE (31722-851-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5ab2d4e4-3c8c-413a-b147-23eafbde313a
Use it
Look up 31722-851 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-851 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-851. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.